ATE236919T1 - Vefahren zur herstellung von erythrmycinderivate - Google Patents

Vefahren zur herstellung von erythrmycinderivate

Info

Publication number
ATE236919T1
ATE236919T1 AT96936904T AT96936904T ATE236919T1 AT E236919 T1 ATE236919 T1 AT E236919T1 AT 96936904 T AT96936904 T AT 96936904T AT 96936904 T AT96936904 T AT 96936904T AT E236919 T1 ATE236919 T1 AT E236919T1
Authority
AT
Austria
Prior art keywords
sup
hydrogen
hydroxy
polar aprotic
erythrmycin
Prior art date
Application number
AT96936904T
Other languages
English (en)
Inventor
Jih-Hua Liu
George A Foster Jr
Stephen H Montgomery
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE236919T1 publication Critical patent/ATE236919T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT96936904T 1995-11-21 1996-10-25 Vefahren zur herstellung von erythrmycinderivate ATE236919T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/560,752 US5872229A (en) 1995-11-21 1995-11-21 Process for 6-O-alkylation of erythromycin derivatives
PCT/US1996/017017 WO1997019096A2 (en) 1995-11-21 1996-10-25 Process for 6-o-alkylation of erythromycin derivatives

Publications (1)

Publication Number Publication Date
ATE236919T1 true ATE236919T1 (de) 2003-04-15

Family

ID=24239215

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96936904T ATE236919T1 (de) 1995-11-21 1996-10-25 Vefahren zur herstellung von erythrmycinderivate

Country Status (11)

Country Link
US (2) US5872229A (de)
EP (1) EP0874862B1 (de)
JP (2) JP2000500488A (de)
AT (1) ATE236919T1 (de)
CA (1) CA2237470C (de)
DE (1) DE69627381T2 (de)
DK (1) DK0874862T3 (de)
ES (1) ES2196184T3 (de)
MX (1) MX9804047A (de)
PT (1) PT874862E (de)
WO (1) WO1997019096A2 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844105A (en) * 1996-07-29 1998-12-01 Abbott Laboratories Preparation of crystal form II of clarithromycin
CA2261732C (en) * 1996-07-29 2001-07-24 Abbott Laboratories Preparation of crystal form ii of clarithromycin
US5858986A (en) 1996-07-29 1999-01-12 Abbott Laboratories Crystal form I of clarithromycin
US5945405A (en) 1997-01-17 1999-08-31 Abbott Laboratories Crystal form O of clarithromycin
US5892008A (en) * 1997-12-16 1999-04-06 Abbott Laboratories Process for the preparation of 6-O-methyl erythromycin a using 9-hydroxy erythromycin derivatives
KR100317907B1 (ko) * 1998-11-24 2001-12-24 김 완 주 신규한 중간체, 이를 이용한 마크로라이드계 항생제의제조방법
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
KR100336447B1 (ko) * 1999-11-24 2002-05-15 민경윤 클라리스로마이신의 개선된 제조방법
US6627743B1 (en) 1999-12-03 2003-09-30 Abbott Laboratories 6-O-methylerythromycin A crystal form III
AU783055B2 (en) * 1999-12-16 2005-09-22 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin polymorphs and novel polymorph IV
RU2002118308A (ru) 2000-01-11 2004-02-20 Тева Фамэситикл Индастрис Лтд. (Il) Способы получения полиморфных модификаций кларитромицина
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) * 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
HUP0302466A2 (hu) * 2000-02-29 2003-11-28 Teva Pharmaceutical Industries Ltd. Eljárások clarithromycin, clarithromycin intermedier, gyakorlatilag oximmentes clarithromycin és ezt tartalmazó gyógyszerkészítmény előállítására
ATE297941T1 (de) * 2000-03-15 2005-07-15 Hanmi Pharm Ind Co Ltd Verfahren zur herstellung von einer kristallinen form ii von clarythromycin
KR20000037126A (ko) * 2000-04-08 2000-07-05 김용규 6-메틸 에리스로마이신 ａ의 제조방법
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6455680B1 (en) 2000-12-21 2002-09-24 Abbott Laboratories Methods utilizing aryl thioimines in synthesis of erythromycin derivatives
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
TWI246515B (en) 2001-05-30 2006-01-01 Abbott Lab An arylation method for the functionalization of O-allyl erythromycin derivatives
US7435805B2 (en) 2003-05-30 2008-10-14 Glaxpsmithkline Istrazivacki O-alkyl macrolide and azalide derivatives and regioselective process for their preparation
AU2004258953B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005009365A2 (en) * 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
CA2533358C (en) * 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
US8758820B2 (en) * 2003-08-11 2014-06-24 Shionogi Inc. Robust pellet
JP2007502294A (ja) * 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
US8246996B2 (en) * 2003-08-29 2012-08-21 Shionogi Inc. Antibiotic product, use and formulation thereof
JP2007513869A (ja) * 2003-09-15 2007-05-31 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2007517039A (ja) * 2003-12-24 2007-06-28 アドバンシス ファーマスーティカル コーポレイション 変性放出製剤の吸収増強
US8715727B2 (en) * 2004-07-02 2014-05-06 Shionogi Inc. Tablet for pulsed delivery
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2009023191A2 (en) * 2007-08-09 2009-02-19 Teva Pharmaceutical Industries Ltd. An improved process for the preparation of clarithromycin

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869444A (en) 1972-10-10 1975-03-04 Abbott Lab Esters of erythromycin oxime
FR2473525A1 (fr) 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4331803A (en) 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
US4336368A (en) 1981-04-20 1982-06-22 Pfizer Inc. 4 Deoxy-4-methylene oleandomycin and derivatives thereof
JPS5896095A (ja) 1981-11-30 1983-06-07 Taisho Pharmaceut Co Ltd １１−ｏ−アルキルエリスロマイシンａ誘導体
JPS5896097A (ja) 1981-12-01 1983-06-07 Taisho Pharmaceut Co Ltd エリスロマイシンｂ誘導体
JPS5896098A (ja) 1981-12-03 1983-06-07 Taisho Pharmaceut Co Ltd エリスロマイシンａ誘導体
US4526889A (en) 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
JPS60120895A (ja) * 1983-12-02 1985-06-28 Taisho Pharmaceut Co Ltd ６−０−メチル−２′−０，ν−ビス（ベンジルオキシカルボニル）−ν−デメチルエリスロマイシンａの製法
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
JPS61103890A (ja) 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
GB8506380D0 (en) 1985-03-12 1985-04-11 Beecham Group Plc Chemical compounds
EP0201166B1 (de) 1985-03-12 1990-02-07 Beecham Group Plc Erythromycin-Derivate
US4670549A (en) 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
JPS61229895A (ja) 1985-04-03 1986-10-14 Nippon Zeon Co Ltd 保護化デス−ｎ−メチルエリスロマイシン誘導体
US4640910A (en) 1985-11-12 1987-02-03 Abbott Laboratories Erythromycin A silylated compounds and method of use
JPS63107994A (ja) 1986-05-02 1988-05-12 Taisho Pharmaceut Co Ltd エリスロマイシン誘導体
US4740502A (en) 1986-06-20 1988-04-26 Abbott Laboratories Semisynthetic erythromycin antibiotics
JPH0764867B2 (ja) * 1986-09-18 1995-07-12 大正製薬株式会社 ６−ｏ−メチルエリスロマイシンａ誘導体およびその製造方法
DE3782994T2 (de) * 1986-09-18 1993-04-08 Taisho Pharma Co Ltd Erythromycin-a-derivate und verfahren zu ihrer herstellung.
JP2526951B2 (ja) * 1986-12-17 1996-08-21 大正製薬株式会社 エリスロマイシンａ誘導体およびその製造方法
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
JP2751385B2 (ja) 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
JP2782793B2 (ja) * 1988-06-15 1998-08-06 大正製薬株式会社 エリスロマイシンａ誘導体およびその製造方法
US5302705A (en) 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives

Also Published As

Publication number Publication date
PT874862E (pt) 2003-08-29
ES2196184T3 (es) 2003-12-16
WO1997019096A3 (en) 1997-07-03
MX9804047A (es) 1998-09-30
DE69627381T2 (de) 2004-03-25
JP2008110976A (ja) 2008-05-15
EP0874862B1 (de) 2003-04-09
CA2237470C (en) 2005-01-18
DK0874862T3 (da) 2003-07-28
USRE39383E1 (en) 2006-11-07
CA2237470A1 (en) 1997-05-29
JP2000500488A (ja) 2000-01-18
WO1997019096A2 (en) 1997-05-29
DE69627381D1 (de) 2003-05-15
US5872229A (en) 1999-02-16
EP0874862A2 (de) 1998-11-04

Similar Documents

Publication Publication Date Title
DE69627381D1 (de) Vefahren zur herstellung von erythrmycinderivate
DE59810363D1 (de) Verfahren zur herstellung von triazolinthion-derivaten
HUT37141A (en) Process for production of substituted 5,11-dihydro-6h-dibenz /b,e/ azepin-6-ons
MY109628A (en) An improved proces for the preparation of substituted indoline derivatives
MX9304378A (es) Metodo de preparacion de derivados de carbamato defisostigmina a partir de eseretoles.
DE69909165D1 (de) Verfahren zur Herstellung von N-Glycyltyrosin
KR880701234A (ko) 신규 비페닐 유도체와 그의 제조 방법 및 용도
KR970074748A (ko) 3-아미노 치환된 크로토네이트의 제조방법
PT968189E (pt) Processo para a preparacao de acidos nicotinicos
MX9304397A (es) Metodo de preparacion de derivados de carbamato de disoestigmina a partir de fisoestigmina.
BG103319A (en) Method for the preparation of hydroxamic acids
EP1092714A3 (de) Verfahren zur Herstellung von Benzo[b]thiophenen
DE3781189D1 (de) Verfahren zur herstellung von oxazinobenzothiazin-6,6-dioxidderivaten.
GR3002989T3 (en) Process for the production of n-acylated mercapto-alpha-amino acids
CA2005596A1 (en) Preparation of 2-amino-4-fluoropyrimidine derivatives
Dalla Croce et al. 1, 3‐Dipolar cycloaddition of nitrones with α, β‐unsaturated sulfones
ATE245149T1 (de) Verfahren zur herstellung von alkoxytriazolinonen
DK1109782T3 (da) Fremgangsmåde til fremstilling af N-beskyttede azetidin-2-carboxylsyrer (AzeOH'er)
TW227003B (de)
BR0016506A (pt) Processo para preparar e isolar a 9-deoxo-9(z)-hidroxiiminoeritromicina a
ES8107190A1 (es) Un procedimiento para la preparacion de w-lactamas que con- tienen 5 a 14 atomos de carbono
GR3021336T3 (en) New process for the preparation of 20-oxo, 17-alpha, 21-dihydroxy derivatives of pregnane and new intermediates thereof.
HUP0000144A2 (hu) Eljárás hidroxi-heteroaromás vegyületek aril-aminokká való átalakítására
KR940007004A (ko) 4-메톡시벤질-1, 2, 3, 4, 5, 6, 7, 8- 옥타히드로이소퀴놀린의 제조방법
KR880007437A (ko) 카르복실산 아미드의 제조 방법

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0874862

Country of ref document: EP

REN Ceased due to non-payment of the annual fee